FHB
RIGL icon

First Hawaiian Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

First Hawaiian Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,348
Closed -$185K – 881
2022
Q2 		$185K Hold
16,348
– – 0.01% 823
2022
Q1 		$489K Sell
16,348
-1,883
-10% -$51K 0.02% 615
2021
Q4 		$483K Buy
+18,231
New +$550K 0.01% 645

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Hawaiian Bank's RIGL Position: Q3 2022 in Review

First Hawaiian Bank sold out of Rigel Pharmaceuticals (RIGL) in Q3 2022, closing a stake of 16,348 shares — an estimated $185K sold.

First Hawaiian Bank first reported a position in RIGL in Q4 2021 and held it in 3 quarters. The position peaked at $489K in Q1 2022. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2022.

  • First Hawaiian Bank reported no remaining Rigel Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • First Hawaiian Bank sold 16,348 Rigel Pharmaceuticals shares in Q3 2022, an estimated $185K.
  • First Hawaiian Bank first reported a position in Rigel Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • First Hawaiian Bank's Rigel Pharmaceuticals position peaked at $489K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2022.

Based on First Hawaiian Bank's 13F filing for Q3 2022, filed 5 Oct 2022.